← ANALYST RATINGS · TIPRANKS
Centene (CNC): analyst forecast and price target
Analyst consensus
Moderate Buy4 Buy5 Hold0 Sell
Ratings of 9 analysts in the last 3 months · top analysts only12-month forecast
Based on 9 price targets given in the last 3 months, the average target is $73.75, the highest $80.00, the lowest $66.00. The average is +6.6% from the last price of $69.16.
Analyst ratings 20
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $73.00 → $68.00−6.8% | Hold | −1.7% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $76.00 → $71.00−6.6% | Buy | +2.7% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $72.00 → $67.00−6.9% | Hold | −3.1% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $70.00 → $66.00−5.7% | Hold | −4.6% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $74.00 → $70.00−5.4% | Hold | +1.2% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $73.00 → $68.00−6.8% | Hold | −1.7% | Reiterated | 08.10.26on TipRanks 12:05 | — | |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $71.00 | Hold | +2.7% | Reiterated | 07.10.26on TipRanks Oct 8 21:45 | +0.8%next day −0.3% · 5 days +8.9% | ↗ |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $79.00 | Buy | +14.2% | Reiterated | 05.10.26on TipRanks 07:30 | +1.4%next day −0.1% · 5 days +3.8% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | $80.00 | Buy | +15.7% | Reiterated | 24.09.26on TipRanks 05:15 | −0.2%next day −0.7% · 5 days −1.1% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $80.00 | Buy | +15.7% | Reiterated | 17.09.26on TipRanks 04:35 | +0.5%next day −3.1% · 5 days −8.6% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $69.00 | Hold | −0.2% | Reiterated | 15.09.26on TipRanks 07:20 | −2.1%next day −2.0% · 5 days −8.8% | ↗ |
| John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% | J.P. Morgan | $67.00 | Hold | −3.1% | Assigned | 20.08.26on TipRanks 07:50 | 0.0%next day +1.0% · 5 days +0.7% | ↗ |
| John Staszak★★★★★★★★★★#835 · hits 59% · avg +8.8% | Argus Research | $80.00 | Buy | +15.7% | Upgrade | 10.08.26on TipRanks Aug 11 08:35 | +1.2%next day −2.2% · 5 days −3.2% | ↗ |
| Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% | TD Cowen | $65.00 | Hold | −6.0% | Assigned | 30.07.26on TipRanks Jul 29 03:10 | −1.7%next day −3.3% · 5 days +2.8% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $57.00 → $66.00+15.8% | Hold | −4.6% | Reiterated | 29.07.26on TipRanks 08:17 | −1.7%next day −3.3% · 5 days +2.8% | ↗ |
| A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% | UBS | $61.00 → $70.00+14.8% | Hold | +1.2% | Reiterated | 29.07.26on TipRanks 08:08 | −1.7%next day −3.3% · 5 days +2.8% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $78.00 → $80.00+2.6% | Buy | +15.7% | Reiterated | 29.07.26on TipRanks 07:48 | −1.7%next day −3.3% · 5 days +2.8% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $46.00 → $66.00+43.5% | Hold | −4.6% | Reiterated | 29.07.26on TipRanks 06:51 | −1.7%next day −3.3% · 5 days +2.8% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $75.00 | Buy | +8.4% | Reiterated | 28.07.26on TipRanks Jul 29 08:50 | −0.5%next day −1.7% · 5 days −3.9% | ↗ |
| Jason Cassorla★★★★★★★★★★#3435 · hits 57% · avg +5.7% | Guggenheim | — | Hold | — | Reiterated | 28.07.26on TipRanks Jul 29 07:41 | −0.5%next day −1.7% · 5 days −3.9% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $63.00 → $69.00+9.5% | Hold | −0.2% | Reiterated | 13.07.26on TipRanks 08:15 | +2.2%next day +0.3% · 5 days −2.6% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | $80.00 | Buy | +15.7% | Upgrade | 20.05.26on TipRanks 21:20 | −1.1%next day +2.0% · 5 days +1.3% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $45.00 → $58.00+28.9% | Buy | −16.1% | Assigned | 29.04.26on TipRanks 08:00 | +8.9%next day −1.5% · 5 days −0.6% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $32.00 → $40.00+25.0% | Sell | −42.2% | Reiterated | 29.04.26on TipRanks 07:30 | +8.9%next day −1.5% · 5 days −0.6% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $39.00 | Hold | −43.6% | Reiterated | 20.04.26on TipRanks 05:40 | +0.6%next day +2.8% · 5 days +12.6% | ↗ |
| Unknown Analyst | Roth MKM | $43.00 → $45.00+4.7% | Buy | −34.9% | Reiterated | 30.10.25on TipRanks 08:20 | −5.1%next day +0.7% · 5 days +7.3% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Centene
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $72.64 at a price of $62.12 (+16.9%); now: $72.92 at $69.16 (+5.4%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 9 | 8 | 10 | 10 | 7 |
| Hold | 9 | 11 | 14 | 11 | 8 | 2 |
| Sell | 3 | 2 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 27.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.10 (from $0.00 to $0.33). Last quarter: $2.51.
Sales
Next quarter’s sales estimate — $47.1B (from $45.6B to $49.2B). Last quarter: $53.6B.
Best top-analyst consensus in the sector · Healthcare
About Centene
- CEO: Sarah McGinty London
- Employees: 61,100
- Centene Plaza, St. Louis, MO, 63105, US
- www.centene.com
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Data from the stock’s TipRanks forecast page, read 65 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗